Tag: Regulation

FTC Emphasizes Compliance in Vehicle Price Advertising for Dealerships

FTC warns 97 dealerships on vehicle price advertising compliance to protect consumers and uphold automotive insurance integrity.

San Francisco Health Care Fund Transfer: A Budgetary Shift

San Francisco plans a $200 million transfer from health care mandate funds to address deficits, impacting employer contributions and worker benefits.

Florida Legislature's Session Ends Without Key Insurance Measures

Explore how Florida's legislative session impacts homeowners insurance costs and the stability of public sector unions, vital for educators and insurance stakeholders.

Medicare to Cover CBD Products: A Transformative Pilot Program

Washington's pilot program will allow Medicare coverage for CBD, enhancing access to alternative therapies while raising concerns on product safety and regulatory standards.

Debate over Medicare Advantage Reimbursement Rates Sparks Public Outcry

Explore the debate over Medicare Advantage reimbursement rates and its implications for the insurance industry. Join the conversation around public comments and advocacy.

MTA Partners with Governor Hochul to Address High Car Insurance Rates

Governor Hochul and MTA tackle rising car insurance rates, proposing reforms to reduce fraudulent claims and save policyholders money.

New Legislation on Prior Authorization in Health Insurance

Discover how new legislation on prior authorization is transforming health insurance by reducing delays and regulatory burdens for providers.

Opposition to Proposed Federal Payment Rule Impacting ACA Exchanges

A coalition of state attorneys general warns against a federal rule altering ACA exchanges, raising health coverage costs and risking insurance market stability.

AHA Responds to CMS Proposed Parameters for 2027

AHA emphasizes the need for patient protections and affordable care in response to CMS’s proposed 2027 payment parameters. Discover key insights and recommendations.

Senate Hearing on Drug Supply Chain and Bipartisan Support for Domestic Manufacturing

Discover key insights from the Senate hearing on drug supply chain reforms, including bipartisan support for domestic drug manufacturing and CMS initiatives.